These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36876375)

  • 21. The dynamic changes of vaginal microecosystem in patients with recurrent vulvovaginal candidiasis: a retrospective study of 800 patients.
    Yue XA; Chen P; Tang Y; Wu X; Hu Z
    Arch Gynecol Obstet; 2015 Dec; 292(6):1285-94. PubMed ID: 26041326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis and Long-Term Outcome of Women With Idiopathic Recurrent Vulvovaginal Candidiasis Caused by Candida albicans.
    Collins LM; Moore R; Sobel JD
    J Low Genit Tract Dis; 2020 Jan; 24(1):48-52. PubMed ID: 31860575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
    Pang Q; Liu W; Cui F; Kan S; Li X
    Mycopathologia; 2022 Dec; 187(5-6):427-437. PubMed ID: 36209322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy.
    Sun Z; Ge X; Qiu B; Xiang Z; Jiang C; Wu J; Li Y
    Front Cell Infect Microbiol; 2023; 13():1123026. PubMed ID: 36816582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal microbiological flora and sexually transmitted diseases in women with recurrent or current vulvovaginal candidiasis.
    Zdolsek B; Hellberg D; Fröman G; Nilsson S; Mårdh PA
    Infection; 1995; 23(2):81-4. PubMed ID: 7622268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbicidal activity of neutrophils is inhibited by isolates from recurrent vaginal candidiasis (RVVC) caused by Candida albicans through fungal thioredoxin reductase.
    Ratti BA; Godoy JS; de Souza Bonfim Mendonça P; Bidóia DL; Nakamura TU; Nakamura CV; Lopes Consolaro ME; Estivalet Svidzinski TI; de Oliveira Silva S
    Cell Immunol; 2015 Jan; 293(1):22-9. PubMed ID: 25497972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite analysis of Candida isolates from recurrent vulvovaginal candidiasis.
    Amouri I; Sellami H; Abbes S; Hadrich I; Mahfoudh N; Makni H; Ayadi A
    J Med Microbiol; 2012 Aug; 61(Pt 8):1091-1096. PubMed ID: 22538998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
    Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species Distribution and Antifungal Susceptibility Profiles of Isolates from Women with Nonrecurrent and Recurrent Vulvovaginal Candidiasis.
    Rolo J; Faria-Gonçalves P; Barata T; Oliveira AS; Gaspar C; Ferreira SS; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Costa-de-Oliveira S; Palmeira-de-Oliveira A
    Microb Drug Resist; 2021 Aug; 27(8):1087-1095. PubMed ID: 33646045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.
    Consolaro ME; Albertoni TA; Svidzinski AE; Peralta RM; Svidzinski TI
    Mycopathologia; 2005 Jun; 159(4):501-7. PubMed ID: 15983735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
    Cassone A
    BJOG; 2015 May; 122(6):785-794. PubMed ID: 25052208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
    J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment for recurrent vulvovaginal candidiasis (thrush).
    Cooke G; Watson C; Deckx L; Pirotta M; Smith J; van Driel ML
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD009151. PubMed ID: 35005777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.
    Fidel PL; Barousse M; Espinosa T; Ficarra M; Sturtevant J; Martin DH; Quayle AJ; Dunlap K
    Infect Immun; 2004 May; 72(5):2939-46. PubMed ID: 15102806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis.
    Zhu YX; Li T; Fan SR; Liu XP; Liang YH; Liu P
    Health Qual Life Outcomes; 2016 Apr; 14():65. PubMed ID: 27129474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X; Li T; Chen X; Wang S; Liu Z
    BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.